These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

110 related items for PubMed ID: 19337648

  • 1. Severe autoimmune hemolytic anemia complicated with liver decompensation and invasive aspergillosis in a patient with chronic hepatitis C during treatment with peg-interferon-a and ribavirin.
    Sykia A, Gigi E, Sinakos E, Bibashi E, Bellou A, Raptopoulou-Gigi M.
    J Gastrointestin Liver Dis; 2009 Mar; 18(1):118-9. PubMed ID: 19337648
    [No Abstract] [Full Text] [Related]

  • 2. Severe autoimmune hemolytic anemia in a patient with chronic hepatitis C during treatment with peginterferon alfa-2a and ribavirin.
    Cauli C, Serra G, Chessa L, Balestrieri C, Scioscia R, Lai ME, Farci P.
    Haematologica; 2006 Jun; 91(6 Suppl):ECR26. PubMed ID: 16785129
    [Abstract] [Full Text] [Related]

  • 3. Severe autoimmune hemolytic anemia in a patient with chronic hepatitis C during treatment with Peg interferon alfa-2a and ribavirin.
    Ennaifer R, Cheikh M, Romdhane H, Hefaiedh R, Ben Nejma H, Bel Hadj N.
    Tunis Med; 2014 Jan; 92(1):42-3. PubMed ID: 24879173
    [No Abstract] [Full Text] [Related]

  • 4. [Autoimmune hemolytic anemia in a case of chronic hepatitis type C 56 weeks after initiation of second line treatment with pegylated interferon alpha2b/ribavirin combination therapy].
    Nishino R, Ikeda N, Unoura M.
    Nihon Shokakibyo Gakkai Zasshi; 2011 Sep; 108(9):1571-8. PubMed ID: 21891998
    [Abstract] [Full Text] [Related]

  • 5. Autoimmune disorders during interferon therapy in a patient with chronic hepatitis C infection: how many of them can be observed in a single patient?
    Hrstic I, Huic D, Bilusic M, Vucelic B.
    J Clin Gastroenterol; 2006 Apr; 40(4):367-8. PubMed ID: 16633111
    [No Abstract] [Full Text] [Related]

  • 6. Hemolytic anemia during pegylated IFN-alpha2b plus ribavirin treatment for chronic hepatitis C: ribavirin is not always the culprit.
    Gentile I, Viola C, Reynaud L, Borrelli F, Cerini R, Ciampi R, Piazza M, Borgia G.
    J Interferon Cytokine Res; 2005 May; 25(5):283-5. PubMed ID: 15871666
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Autoimmune hemolytic anemia in HCV/HIV coinfected patients during treatment with pegylated alpha-2a interferon plus ribavirin.
    Vilar FC, Castro Gd, Moya MJ, Martinelli Ade L, De Santis GC, Cozac AP, Figueiredo JF.
    Rev Soc Bras Med Trop; 2007 May; 40(6):678-80. PubMed ID: 18200424
    [Abstract] [Full Text] [Related]

  • 9. Alopecia universalis: a rare side effect seen on chronic hepatitis C treatment with peg-IFN and ribavirin.
    Demirturk N, Aykin N, Demirdal T, Cevik F.
    Eur J Dermatol; 2006 May; 16(5):579-80. PubMed ID: 17101483
    [No Abstract] [Full Text] [Related]

  • 10. Tolerability of Peg interferon-alpha2b and Ribavirin therapy in patients with chronic hepatitis C and glucose-6-phosphate dehydrogenase deficiency.
    Demelia L, Civolani A, Murgia D, Murru A, Sorbello O, Rizzetto M.
    J Hepatol; 2007 Jan; 46(1):171-3. PubMed ID: 17107736
    [No Abstract] [Full Text] [Related]

  • 11. Vitiligo after combination therapy of pegylated interferon-α-2a, ribavirin and vitamin D in a patient with chronic hepatitis C.
    Oiso N, Sato M, Kawada A.
    J Dermatol; 2013 Sep; 40(9):772-3. PubMed ID: 23855823
    [No Abstract] [Full Text] [Related]

  • 12. A case of irreversible alopecia associated with ribavirin and peg-interferon therapy.
    Shafa S, Borum ML, Igiehon E.
    Eur J Gastroenterol Hepatol; 2010 Jan; 22(1):122-3. PubMed ID: 19959941
    [No Abstract] [Full Text] [Related]

  • 13. Iatrogenic hyperpigmentation in chronically infected hepatitis C patients treated with pegylated interferon and ribavirin.
    Lin J, Lott JP, Amorosa VK, Kovarik CL.
    J Am Acad Dermatol; 2009 May; 60(5):882-3. PubMed ID: 19389538
    [No Abstract] [Full Text] [Related]

  • 14. Cutaneous sarcoidosis associated with pegylated interferon alfa and ribavirin therapy in a patient with chronic hepatitis C.
    Rogers CJ, Romagosa R, Vincek V.
    J Am Acad Dermatol; 2004 Apr; 50(4):649-50. PubMed ID: 15034524
    [No Abstract] [Full Text] [Related]

  • 15. Peginterferon and ribavirin for hepatitis C.
    Ben Salem C, Hmouda H, Bouraoui K.
    N Engl J Med; 2007 Mar 22; 356(12):1270; author reply 1271. PubMed ID: 17380578
    [No Abstract] [Full Text] [Related]

  • 16. Dual onset of type 1 diabetes mellitus and Graves' disease during treatment with pegylated interferon alpha-2b and ribavirin for chronic hepatitis C.
    Hayashi M, Kataoka Y, Tachikawa K, Koguchi H, Tanaka H.
    Diabetes Res Clin Pract; 2009 Nov 22; 86(2):e19-21. PubMed ID: 19744739
    [Abstract] [Full Text] [Related]

  • 17. What caused this lingual hyperpigmentation in a patient with chronic hepatitis C?
    Radha Krishna Y, Itha S.
    Liver Int; 2010 Mar 22; 30(3):416. PubMed ID: 19422481
    [No Abstract] [Full Text] [Related]

  • 18. Thyroid function and changes in ultrasound morphology during antiviral therapy with pegylated interferon and ribavirin in patients with chronic hepatitis C.
    Friedrich-Rust M, Theobald J, Zeuzem S, Bojunga J.
    J Viral Hepat; 2009 Mar 22; 16(3):168-77. PubMed ID: 19175874
    [Abstract] [Full Text] [Related]

  • 19. [Pegylated-interferon alpha plus ribavirin-induced subacute thyroiditis in chronic hepatitis C].
    Abellán Galiana P, Pérez-Lázaro A, Aguilera Sancho-Tello V, Merino Torres JF, Berenguer Haym M, Piñón Sellés F.
    Endocrinol Nutr; 2009 Mar 22; 56(3):136-9. PubMed ID: 19627727
    [Abstract] [Full Text] [Related]

  • 20. Combination pegylated interferon and ribavirin therapy precipitating acute renal failure and exacerbating IgA nephropathy.
    Gordon A, Menahem S, Mitchell J, Jenkins P, Dowling J, Roberts SK.
    Nephrol Dial Transplant; 2004 Aug 22; 19(8):2155. PubMed ID: 15252182
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.